SUMMARY Infarct size was estimated by cumulative creatine kinase MB isoenzyme (CKMB-r) release and by technetium 99m stannous pyrophosphate (TcPYP) scintigraphy in 27 patients with acute anterior myocardial infarction.
In recent years, awareness of the prognostic importance of the extent of myocardial necrosisl 2 and the postulated existence of an ischaemic but potentially viable border zone3 4 have led to attempts to reduce infarct size.5-7 Assessment of the efficacy of such therapeutic intervention in man requires accurate and reliable methods of measuring infarct size which may be applied in the early postinfarct period.
Many different approaches have been tried,8 including analysis of plasma enzyme time-activity curves,9-"1 technetium 99m pyrophosphate (TcPYP) scintigraphy,'2 13 and praecordial electrocardiographic mapping.14 All are open to criticism but creatine kinase (CK) analysis has been regarded as the most accurate and has become accepted as a reference technique. Recently, however, very poor correlation has been reported between CK-derived estimates of myocardial necrosisv and--histological infarct size after experimental infarction in dogs. '5 16 The major factor responsible for this poor correlation was impaired enzyme release into plasma from large infarcts. In the present study we assess whether this is so in patients with myocardial infarcts.
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The study involved 27 patients who fulfilled all the following criteria (a) typical cardiac pain starting started within six hours of admission, (b) 12 lead electrocardiographic changes of anterior myocardial infarction (development of Q waves >.0 04 s duration in one or more of leads I, aVL, V1-6) , and (c) a rise in plasma creatine kinase MB isoenzyme (CKMB) with a typical time-course. Patients over 70 years and those in established cardiogenic shock were excluded.
Initially, a clinical history was taken and examination performed. Twelve lead electrocardiography was carried out daily for three days, on day 7, and before discharge. Blood sampling for the measurement of plasma CKMB was performed four hourly for 24 hours, six hourly for the next 48 hours, and eight-hourly for a further 24 hours or until two consecutive specimens were enzyme negative. Total creatine kinase (CK) was estimated spectrophotometrically by the method of Oliver'7 as modified by Hearse et (Fig. 1) , and to derive an individual disappearance constant (kd) of CKMB from plasma for each patient.'1 The cumulative release of CKMB (CKMB-r) was calculated using a modification20 (Fig. 2 27 showing fairly homogeneous TcPYP uptake in a medium sized anterior infarct (contrast with Fig. 4 region of reduced activity-a configuration which resembles a doughnut (Fig. 4) . In the present study, this "doughnut" pattem was found only with larger infarcts. The maximal infarct area in this group ranged from 42 to 62 cm2 (mean 51 3 ±2 8 cm2) which was significantly greater (p < 0.001) than that of the remainder (11 to 48 cm2; mean 28-1 +2'5 cm2). In five out of the eight patients with "doughnut" scintigrams the 12 lead electrocardiograph showed changes of extensive anterior myocardial infarction (leads I, aVL, and V1-6) whereas only three out of the remaining 19 patients had similar changes. Plasma enzyme data and the derived CKMB-r values are presented in Table 2 . CKMB-r ranged from 74 to 395 mIU/ml. The mean ( ± SEM) for the eight patients with "doughnut" scintigrams was 236-6 ±22-5 mIU/ml which did not differ significantly (p > 0-5) from that of the remaining 19 patients (212-4 ±25'0 mIU/ml).
Overall correlation between TcPYP infarct area and CKMB was moderate (r=0-60) (Fig. 5) . In the eight patients with "doughnut" scintigrams, cor-relation was poor (r=028) and their exclusion produced very good correlation in the remainder (r=086) (Fig. 6 tracer accumulation between the centre and periphery of the infarct are maximal in large infarcts and may result in a "doughnut" pattern of tracer distribution (Fig. 4 and 7) . This scintigraphic appearance has been observed frequently in dogs30 and occasionally in man13 26 after extensive anterior infarction.
In the present study, eight patients showed this appearance and in these, scintigraphic infarct area is significantly more extensive (p < 0 001) than in those with homogeneous images. Correlation between scintigraphic and enzymatic estimates of infarct size in this group is poor (r =0-28). Its exclusion results in substantial improvement in correlation (r=0-86), suggesting that the reduction in overall correlation (r=0-6) is primarily because of these patients with tions observed. Secondly, in seven of the eight patients with "doughnut" scintigrams, CKMB-r indicated only a small or medium sized infarct, whereas standard electrocardiography indicated large anterior infarcts in all and extensive changes involving leads I, aVL, and V1-6 in five. Thirdly, Roe et al. 31 showed the dependence of enzyme release on perfusion by showing that the appearance rate of enzyme in plasma was related to alterations of infarct blood flow rather than to the extent of infarction and that further reduction of blood flow to an already ischaemic zone resulted in an immediate decrease in the amount of CK being released.32 Since perfusion is much reduced in the central regions of large infarcts, the release of CKMB into plasma by the normal channels is impaired. A greater proportion than usual therefore occurs via the lymphatics in which CKMB inactivation is known to occur.33 3 The resulting plasma enzyme levels are thus reduced and their analysis underestimates infarct size (Fig. 8) .
Scintigraphic estimation of infarct size, however, is not affected in the same way by alterations in residual perfusion since it is based on the total area of tracer uptake enclosed within the peripheral rim in which perfusion is maintained at levels favouring TcPYP and calcium accumulation.2729 Consequently, in large infarcts, correlation between enzymatic and scintigraphic estimates of the extent of infarction is poor (Fig. 8) 
